I have several questions on filing for extension under the Waxman-Hatch
ruling:
1. Given that an extension is allowed for a particle drug, can other related
patents which cover that drug also be extended?
2. Is there a time limit for filing extensions? It looks like from the rule
in the CFR the limitation is "60 days period beginning on the date the
product first received permission for commercial marketing...". But I
believe I have seen exceptions to this rule.
3. Is there a good resource for discussion of the Waxman Hatch (in somewhat
layman terms)?
Any help would be greatly appreciated.
Thank you,
Shiela Loggins
Ciba Specialty Chemical Corp.
Tarrytown, NY 10591
This archive was generated by hypermail 2b29 : Fri Aug 10 2001 - 15:58:49 EDT